بر اساس عنوان

1
Hemoptysis and Hematuria as the Initial Symptoms of COVID-19: a Case Report
2
Hemoptysis and Massive Hemothorax as Presentation of Intralobar Sequestration
3
Hemoptysis and Upper Gastrointestinal Bleeding In Two Patients Presenting With Aluminum Phosphate Intoxication (Oral and Inhaled): A Case Study
4
Hemoptysis as a Complication of Capitonnage for Management of Pulmonary Hydatid Cyst
5
Hemoptysis as a Rare Presentation of Thoracic Aorta Aneurysm
6
Hemoptysis as an unusual manifestation of right atrial myxoma
7
Hemoptysis caused by aortobronchial fistula
8
Hemoptysis caused by Hughes-Stovin syndrome
9
Hemoptysis demonstrated on Tc99m-sulfur colloid scanning: A rare complication of amoebic liver abscess
10
Hemoptysis from an unusual pulmonary arteriovenous malformation
11
Hemoptysis From Collateral Arteries 12 Years After a Fontan-Type Operation
12
Hemoptysis resulting from unilateral pulmonary artery agenesis
13
Hemoptysis Secondary to Pulmonary Artery Pseudoaneurysm After Necrotizing Pneumonia
14
Hemoptysis secondary to pulmonary pseudoaneurysm 30 years after a gunshot wound
15
Hemoptysis. A rare presentation of a vallecular cyst
16
Hemopump 31, the sternotomy hemopump: Clinical experience
17
Hemopump treatment in patients with postcardiotomy heart failure
18
Hemorheolocical and photoplethysmographical modifications with aging
19
Hemorheological and cardiovascular effects of exercise training in the rehabilitation of elderly patients with chronic obstructive pulmonary disease
20
Hemorheological changes and overproduction of cytokines from immune cells in mild to moderate dementia of the Alzheimer’s type: adverse effects on cerebromicrovascular system.
21
Hemorheological changes with strontium ranelate treatment do not seem to be related to its claimed prothrombotic effects
22
Hemorheology by Microchannel Method in Males with Metabolic Syndrome
23
Hemorrhage activates catecholaminergic neurons sensitive to GABA in the nucleus of the solitary tract with ascending projections to the subfornical organ in rats
24
Hemorrhage Activates Myocardial NFκB and Increases TNF-α in the Heart
25
Hemorrhage after pancreaticoduodenectomy: when is surgery still indicated?
26
Hemorrhage and the Use of Blood Products After Adult Cardiac Operations: Myths and Realities
27
Hemorrhage of the optic dik in normal-tenion glaucoma
28
Hemorrhage Treatment Report of Patients Suffering from Glanzmann’s Thrombasthenia Resulting Hospitalization from 2006 to 2011 at Mofid Children’s Hospital
29
Hemorrhages Seen on Brain Images After Mild Traumatic Brain Injury May Increase the Risk of Post-concussion Syndrome
30
Hemorrhagic and thrombotic disorders due to factor V deficiencies and abnormalities: an updated classification
31
Hemorrhagic ascites: an unusual manifestation of prostate carcinoma
32
Hemorrhagic Auricular Schwannoma: A case report
33
Hemorrhagic bowel syndrome in dairy cattle in Iran: a case report
34
Hemorrhagic brain metastases as a manifestation of metastatic malignant melanoma
35
Hemorrhagic cardiac tamponade in critically ill patients with acute renal failure
36
Hemorrhagic cerebral metastases from thyroid cancer on T2*-weighted gradient echo MRI
37
Hemorrhagic Complication from Glaucoma urgery in Patient on Anticoagulation Therapy or Antiplatelet Therapy Original Reearch Article
38
Hemorrhagic complication in an unupected macular choroidal melanoma
39
Hemorrhagic complications after nephron-sparing surgery: Angiographic diagnosis and management by transcatheter embolization: Heye S, Maleux G, Van Poppel H, Oyen R, Wilms G, Department of Radiology, University Hospitals Gasthuisberg, Belgium
40
Hemorrhagic Complications of Intravenous Heparin Use
41
Hemorrhagic Corpus Luteum is Associated with Ovarian Edema
42
Hemorrhagic Corpus Luteum With Generalized Abdominal Pain in Patients With Idiopathic Thrombocytopenic Purpura
43
Hemorrhagic Cystitis Following Cephalexin Overdose in a Child
44
HEMORRHAGIC DISEASE OF THE NEWBORN: CLINICAL PRESENTATION AND RESPONSE TO TREATMENT WITH VITAMIN K
45
Hemorrhagic enteritis virus induced changes in the lymphocyte subpopulations in turkeys and the effect of experimental immunodeficiency on viral pathogenesis
46
Hemorrhagic enteritis virus induced changes in the lymphocyte subpopulations in turkeys and the effect of experimental immunodeficiency on viral pathogenesis
47
Hemorrhagic Events During Therapy With Recombinant Tissue Plasminogen Activator, Heparin, and Aspirin for Unstable Angina (Thrombolysis In Myocardial Ischemia, Phase IIIB Trial)
48
Hemorrhagic Events in Patients Receiving Heparin or Enoxaparin in Combination With Oral Antithrombotics, NSAIDs, and Antiplatelet Medications: A Multi-Center Case-Series Study
49
Hemorrhagic Fever with Acute Renal Failure: A Report from Kosova
50
Hemorrhagic Fever With Renal Syndrome and Its History in Iran
51
Hemorrhagic Gastritis Associated with Renal Failure, Hemoglobinuria, and Isolation of Clostridium perfringens in a Horse
52
Hemorrhagic pericardial effusion leading to cardiac tamponade, as presenting feature of COVID-19 in a young man: a case report
53
Hemorrhagic Posterior Reversible Encephalopathy Syndrome: A Rare Neurological Complication of COVID-19 Infection
54
Hemorrhagic shock from a ruptured ectopic pregnancy in a patient with a negative urine pregnancy test result
55
Hemorrhagic type Moyamoya disease
56
Hemostasis and exercise
57
Hemostasis as an optimal system
58
Hemostasis by means of a cautery knife equipped with an air spray for burns over a large area
59
Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders
60
Hemostasis in newborns of smoking and nonsmoking mothers, ,
61
Hemostasis in Off-Pump Compared to On-Pump Coronary Artery Bypass Grafting: A Prospective, Randomized Study
62
Hemostasis in Oral Surgery
63
Hemostasis in Overt and Subclinical Hyperthyroidism
64
Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies, , , ,
65
Hemostasis in uncontrolled esophageal variceal bleeding by self−expanding metal stents: a systematic review
66
Hemostasis Management in Pediatric Mechanical Circulatory Support
67
Hemostasis of the femoral vasculature: Shouldn’t we have an answer by now?, ,
68
Hemostasis of Tiger Prawn Penaeus monodon Affected by Vibrio harveyi, Extracellular Products, and a Toxic Cysteine Protease
69
Hemostasis success rates and local complications with collagen after femoral access for cardiac catheterization: Analysis of 6007 published patients, ,
70
Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge
71
Hemostatic Agents
72
Hemostatic agents in orthodontics: A review
73
Hemostatic agents versus sutured bolster during laparoscopic partial nephrectomy
74
Hemostatic capability of rapidly curable glues from gelatin, poly(L-glutamic acid), and carbodiimide
75
Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model
76
Hemostatic effects of aprotinin, tranexamic acid and ε-aminocaproic acid in primary cardiac surgery
77
Hemostatic Efficacy of Ankaferd Blood Stopper in a Swine Bleeding Model
78
Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting
79
Hemostatic factors, atherogenesis and atherosclerosis
80
Hemostatic Molecular Markers Before the Onset of Disseminated Intravascular Coagulation
81
Hemostatic parameters in pulmonary tuberculosis patients after intensive phase treatment
82
Hemostatic responses to maximal exercise in oral contraceptive users
83
Hemostatic risk factors of coronary artery disease in the Chinese
84
Hemostatic Role of TachoSil Surgical Patch in Cardiac Surgery
85
Hemostatic state and atrial fibrillation (The Framingham Offspring Study)
86
Hemostatic Tampon to Reduce Bleeding following Tooth Extraction
87
Hemosuccus pancreaticus as a rare cause of gastrointestinal bleeding: a report of two cases.
88
Hemosuccus Pancreaticus in a Patient with Celiac Trunk Aneurysm
89
Hemothorax as the first manifestation of idiopathic pulmonary arteriovenous malformation
90
Hemothorax in type I neurofibromatosis
91
Hemotoxicity of carbon nanotubes
92
Hemotropic Mycoplasmas in Stray Cats in Kerman, Iran
93
Hemoxygenase-1 in Cardiovascular Disease
94
Hemozoin Enhances Maturation of Murine Bone Marrow Derived Macrophages and Myeloid Dendritic Cells
95
Hemp diseases and pests. Management and biological control. An advanced treatise J.M. McPartland, R.C. Clarke and D.P. Watson; CABI Publishing Wallingford, Oxon, price £49.95 (US$90), ISBN 0-85199-454-7
96
Hemp fibre reinforced cashew nut shell liquid composites
97
Hemp fibre reinforced cashew nut shell liquid composites
98
Hemp fibre reinforced composites using chelator and enzyme treatments
99
Hemp Fibres as Novel Green Support Material for Immobilization of Acidithiobacillus ferrooxidans
100
Hemp seed cake in organic broiler diets
101
Hemp seed/evening primrose oil affects expression of STAT3, IL-17, and FOXP3+ in experimental autoimmune encephalomyelitis
102
Hemp: A more sustainable annual energy crop for climate and energy policy
103
HEMP-derived activated carbon fibers by chemical activation with phosphoric acid
104
Hempel S. The Medical Detective: John Snow and the Mystery of Cholera [title in USA ‘The Strange case of the Broad Street Pump] Granta Books, 2006, pp304 ISBN 1-862-07842-4 Hardback £18.99
105
Hempelʹs Raven paradox: a positive approach to cluster analysis
106
Hempseed protein derived antioxidative peptides: Purification, identification and protection from hydrogen peroxide-induced apoptosis in PC12 cells
107
Hemşehrilik and Favouritism in the Context of Political and Civil Society Organizations
108
HEMŞİRELERİN İŞ GÜCÜ VERİMLİLİĞİNİ ETKİLEYEN ÖRGÜTSEL FAKTÖRLER KONUSUNDAKİ TUTUMLARININ BELİRLENMESİ
109
HEMŞİRELERİN ÖRGÜTSEL VATANDAŞLIK DÜZEYLERİNİN BELİRLENMESİ
110
HEMT modelling using semi-physical expressions for the equilibrium space-charge parameters of the modulation-doped heterojunction
111
Hen egg white as a feeder protein for lipase immobilization
112
Hen egg white fractionation by ion-exchange chromatography
113
Hen Egg Yolk Prevents Bacterial Adherence: A Novel Function for a Familiar Food
114
Hen’s egg white hypersensitivity among a group of Egyptian atopic children
115
Hen’s eggshell strength under impact loading Original Research Article
116
HEN-1, a Secretory Protein with an LDL Receptor Motif, Regulates Sensory Integration and Learning in Caenorhabditis elegans
117
Henbit (Lamium amplexicaule L.) control and forage legume tolerance to selected postemergence herbicides
118
Hencky’s logarithmic strain and dual stress–strain and strain–stress relations in isotropic finite hyperelasticity
119
Hendra (Equine Morbillivirus)
120
Hendra virus influences meningoencephalitis-based mortality: A comprehensive review
121
Hendra Virus: A Highly Lethal Zoonotic Agent
122
Hendra-like virus responsible for epidemic in Malaysia
123
He-Ne Laser Irradiation Encourages reparative processes After cartilage loss in New Zealand rabbits
124
HeNe+: resolution of an apparent disagreement between experiment and theory
125
Hengill geothermal volcanic complex (Iceland) characterized by integrated geophysical observations
126
Henipavirus susceptibility to environmental variables
127
Henk F. Moed, Wolfgang Glänzel and Ulrich Schmoch, Editors, Handbook of Quantitative Science and Technology Research: The Use of Publication and Patent Statistics in Studies of S&T Systems, Kluwer Academic Publishers (2004) ISBN 1 4020 2702 8 Hardback (al
128
Henk Postma, 1921–2005
129
Henkelʹs strategy for Asia Pacific
130
Henna, An Antimicrobial Herbal Medicine With Less Negative Effect on Spermatogonial Stem Cell Culture
131
Henney nomination moves forward
132
Henneyʹs FDA nomination on “hold”
133
Hennie Van Greuning, International financial reporting standards — A practical guide (2nd edition), The World Bank, Washington (USA) (2005) ISBN 0-8213-5910-X x+297 p, US$30.00.
134
Henoch Schonlein Purpura in children: clinical analysis of 120 cases
135
Henoch–Sch ̈onlein Purpura Associated with Lung Cancer: When Paraneoplastic Manifestations Impede Oncological Management
136
Henoch-Schoenlein Purpura Following Severe Acute Respiratory Syndrome Coronavirus-2 Infection: A Case Report
137
Henoch-Schönlein purpura
138
Henoch-Schonlein Purpura Associated with Methicillin-Resistant Staphylococcus aureus Infection
139
Henoch-Schonlein Purpura in A Child Complicated by Fatal Pulmonary Hemorrhage
140
Henoch-Schonlein Purpura in an Elderly Women Presenting with Severe GI Bleeding: A case report
141
Henoch-Schonlein purpura in children
142
Henoch-Schonlein Purpura in Northeast India: Peculiarities in Presentation
143
Henoch-Schönlein purpura with intracerebral hemorrhage
144
Henoch-Schönlein syndrome induced by carbidopa/levodopa
145
Hénon–Heiles potential as a bridge between nontopological solitons of different types
146
HENOSEPILACHNA SEPTIMA DIEKE (COCCINELLIDAE; COLEOPTERA); A NEW RECORD FOR PAKISTAN ALONG WITH NOTES ON ITS TAXONOMY, HOST PLANTS AND DISTRIBUTION
147
HENOSEPILACHNA VIGINTIOCTOPUNCTATA (FAB.) (EPILACHNINAE; COCCINELLIDAE); ITS TAXONOMY, DISTRIBUTION AND HOST PLANTS IN PAKISTAN.
148
Henri Theil, 1924–2000
149
Henri Wallonʹs Theory of Early Child Development: The Role of Emotions
150
Henrian ideality of iron in liquid uranium solvent at high temperatures
151
Henriciʹs transformation and its application to the computation of derivatives of eigensystems
152
Henricus Mattheus Princen
153
Henrik Kacser (1918–1995): an Annotated Bibliography
154
Henrik L Blum
155
Henriksen and Isbell on f-rings
156
Henriksenʼs contributions to residue class rings of analytic and entire functions
157
Henry Adams and the question of posthistoire
158
Henry Arthur Solomon, MD: a conversation with the editor
159
Henry Bowditch and “The Young Stethoscopist”
160
Henry condensations with 4,6-O-benzylidenylated and non-protected d-glucose and l-fucose via DBU-catalysis
161
Henry Darger: Art and Selected Writings: Michael Bonesteel;Rizzoli International Publications, Inc., New York, 2000, 256 pages, 125 color illustrations; hardbound, $85
162
Henry Hobson Richardson and the small public library in America: A study in topology : Breisch, Kenneth A. Cambridge, MA: MIT Press, 1997. 343 pp. $50.00. ISBN: 0-262-2416-0
163
Henry Hugh Higgins and Frederick Price Marrat: the reluctant palaeobotanists and the Ravenhead collection
164
Henry James and the New Woman: A Feminist Reading of The Bostonians
165
Henry kempe memorial lecture—10th International congress on child abuse and neglect : Child abuse and neglect from an indigenous Australianʹs perspective
166
Henry reaction of fluorinated nitro compounds
167
Henry S. Kaplan Distinguished Scientist Award 2003
168
Henry Swan II, MD
169
Henry Swan II, MD
170
Henry Vartan Kehiaian (1929–2009)
171
Henry W. Lane, Martha L. Maznevski, Mark E. Mendenhall and Jeanne McNett, Editors, The Blackwell Handbook of Global Management: A Guide to Managing Complexity, Blackwell Publishers, Malden, MA (2004).
172
Henry, C.J.K. (Ed.) Novel food ingredients for weight control, Woodhead Publishing Ltd., Cambridge, UK, 2007 (xiv + 358 pp., £135.00, ISBN 1-84569-030-4).
173
Henry, C.J.K. (Ed.) Novel food ingredients for weight control, Woodhead Publishing Ltd., Cambridge, UK, 2007 (xiv + 358 pp., £135.00, ISBN 1-84569-030-4).
174
Henry’s constants of butane, isobutane, 1-butene and isobutene in methanol at 255–320 K
175
Henry’s constants of carbon dioxide in methanol at 250–500 K
176
Henry’s constants of methanol in aqueous systems containing salts
177
Henry’s law constant measurements for formaldehyde and benzaldehyde as a function of temperature and water composition
178
Henry’s law constant, octanol–air partition coefficient and supercooled liquid vapor pressure of carbazole as a function of temperature: Application to gas/particle partitioning in the atmosphere
179
Henry’s law constants and isosteric heats of adsorption at zero loading for multi-wall carbon surfaces with different geometries Original Research Article
180
Henry’s law constants and mass transfer coefficients for methyl bromide and 1,3-dichloropropene applied to Florida sandy field soil
181
Henry’s law constants derived from equilibrium static cell measurements for dilute organic–water mixtures
182
Henry’s law constants for hexachlorobenzene, p,p′-DDE and components of technical chlordane and estimates of gas exchange for Lake Ontario
183
Henry’s law constants of methane, nitrogen, oxygen and carbon dioxide in ethanol from 273 to 498 K: Prediction from molecular simulation
184
Henry’s law constants of phenol and mononitrophenols in water and aqueous sulfuric acid Original Research Article
185
Henry–Nef reaction: a practical and versatile chiral pool route to 2-substituted pyrrolidine and piperidine alkaloids
186
Henryʹs constants of gases and volatile organic compounds in aqueous solutions
187
Henryʹs constants of n-alkanols (methanol through n-hexanol) in water at temperatures between 40°C and 90°C
188
Henryʹs constants of propane, propene, trans-2-butene and 1,3-butadiene in methanol at 255–320 K
189
Henryʹs Law and the solubilities of reactant gases in the modelling of PEM fuel cells
190
Henryʹs Law coefficients of chloropicrin and methyl isothiocyanate
191
Henryʹs law constant and related coefficients for aqueous hydrocarbons, CO2 and H2S over a wide range of temperature and pressure
192
Henryʹs law constant measurements for phenol, o-, m-, and p-cresol as a function of temperature
193
Henryʹs law constants and hydrolysis rate constants of 2,2,2-trifluoroethyl acetate and methyl trifluoroacetate
194
Henryʹs law constants for a diverse set of organic chemicals: Experimental determination and comparison of estimation methods
195
Henryʹs law constants for C2–C3 fluorinated alcohols and their wet deposition in the atmosphere
196
Henryʹs law constants for α-, β-, and γ-hexachlorocyclohexanes (HCHs) as a function of temperature and revised estimates of gas exchange in Arctic regions
197
Henryʹs law constants measurements of alachlor and dichlorvos between 283 and 298 K
198
Henryʹs law constants measurements of the nonylphenol isomer 4(3′,5′-dimethyl-3′-heptyl)-phenol, tertiary octylphenol and γ-hexachlorocyclohexane between 278 and 298 K
199
Henryʹs law constants of 1-butene, 2-methylpropene, trans-2-butene, and 1,3-butadiene in methanol at 374–490 K
200
Henryʹs law constants of 2,2,2-trifluoroethyl formate, ethyl trifluoroacetate, and non-fluorinated analogous esters
201
Henryʹs law constants of halogenated organic acids
202
Henryʹs law constants of propane, propene, butane, and 2-methylpropane in methanol at 374–490 K
203
Hens are motivated to dustbathe in peat irrespective of being reared with or without a suitable dustbathing substrate
204
Hens’ welfare to egg quality: a European perspective
205
Hensel′s Lemma and the Divisibility by Primes of Stirling-like Numbers Original Research Article
206
Henselian residually p-adically closed fields
207
Henselian Valued Stable Fields
208
Hensleyʼs problem for complex and non-Archimedean meromorphic functions
209
Henstock type integral in harmonic analysis on zero-dimensional groups
210
Henstock–Kurzweil delta and nabla integrals ✩
211
Henstock–Kurzweil–Pettis integrability of compact valued multifunctions with values in an arbitrary Banach space
212
Henstockʹs multiple wiener integral and henstockʹs version of hu-meyer theorem
213
heoretical studies on shuttle checking: Part II-Shuttle checking by swell P K Hari K N Gupta B K Behera S G Joshi
214
heoretical studies on shuttle checking: Part II-Shuttle checking by swell P K Hari K N Gupta B K Behera S G Joshi
215
heory of Markov systems with fuzzy states
216
Hep atop rotective Potentials of Ghrelin and/or N-Acetyl Cysteine in Thioacetamide Induced Chronic Liver Injury in Rats
217
Hep atop rotective Role for Querectin in Diabetic Rats: Hypolipidemic and Antioxidant Effects
218
HEP computing in Korea Original Research Article
219
HEp-2 cell classification using rotation invariant co-occurrence among local binary patterns
220
HEp-2 cell image classification with multiple linear descriptors
221
HEp-2 cell pattern classification with discriminative dictionary learning
222
HEp-2 cells classification via sparse representation of textural features fused into dissimilarity space
223
HEp-2 fluorescence pattern classification
224
HEp-2 image classification using intensity order pooling based features and bag of words
225
HEPACAM1 and 2 are differentially regulated in canine mammary adenomas and carcinomas and its lymph node metastases
226
Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks
227
Heparan sulfate abnormalities in exostosis growth plates
228
Heparan sulfate is the main sulfated glycosaminoglycan species in internal organs of the male cockroach, Periplaneta americana
229
Heparan sulfate isomers in cerebral arteries of Japanese women with aging and with atherosclerosis—heparitinase and high-performance liquid chromatography determinations
230
Heparan sulfate proteoglycans. Essential co-factors in receptor-mediated processes with relevance to the biology of the vascular wall Original Research Article
231
Heparan Sulfate: A Complex Polymer Charged with Biological Activity
232
Heparan sulphate proteoglycans in Alzheimerʹs disease and amyloid-related disorders
233
Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation
234
Heparanase expression in human leukemias is restricted to acute myeloid leukemias
235
Heparanase Gene Hypomethylation as a Potential Biomarker for Precision Screening of Bladder Cancer
236
Heparanase promotes bone destruction and invasiveness in prostate cancer
237
Heparanase Regulates Thrombosis in Vascular Injury and Stent-Induced Flow Disturbance
238
Heparanase, heparan sulfate and perlecan distribution along with the vascular penetration during stellate reticulum retraction in the mouse enamel organ
239
Heparan-like molecules induce the repair of skull defects
240
Heparin accelerates liver regeneration following portal branch ligation in normal and cirrhotic rats with increased plasma hepatocyte growth factor levels
241
Heparin Activates PKR by Inducing Dimerization
242
Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood
243
Heparin after percutaneous intervention (HAPI): prospective multicenter randomized trial of three heparin regimens after successful coronary intervention
244
Heparin and aspirin attenuate placental apoptosis in vitro: Implications for early pregnancy failure
245
Heparin and aspirin in stroke
246
Heparin and aspirin in stroke
247
Heparin and aspirin in unstable angina: Insufficient sample size may lead to erroneous conclusions
248
Heparin and inflammatory bowel disease
249
Heparin and its derivatives in the treatment of arterial thrombosis: a review
250
Heparin and Low Molecular Weight Heparin Decrease Nitric Oxide Production by Human Polymorphonuclear Cells
251
heparin and platelet function
252
Heparin and the nonanticoagulant N-acetyl heparin attenuate capillary no-reflow after normothermic ischemia of the lung
253
Heparin antiproliferative activity on bovine pulmonary artery smooth muscle cells requires both N-acetylation and N-sulfonation Original Research Article
254
Heparin as adjunctive therapy to coronary thrombolysis in acute myocardial infarction
255
Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction
256
Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-β in vitro
257
Heparin binding activity of orf virus F1L protein
258
Heparin Binding and Augmentation of C1 Inhibitor Activity
259
Heparin Binds to the Laminin α4 Chain LG4 Domain at a Site Different from that Found for Other Laminins
260
Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass
261
Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass
262
Heparin Causes the Accumulation of Heparan Sulfate in Cultures of Arterial Smooth Muscle Cells
263
Heparin coated Palmaz-Schatz™ stents are highly thrombo-resistant: baboon A-V shunt study
264
Heparin coated poly(alkylcyanoacrylate) nanoparticles coupled to hemoglobin: a new oxygen carrier
265
Heparin coating dramatically reduces platelet deposition on incompletely deployed Palmaz-Schatz™ in the baboon A-V shunt
266
Heparin coating of bypass systems
267
Heparin coating of poly(ethylene terephthalate) decreases hydrophobicity, monocyte/leukocyte interaction and tissue interaction
268
Heparin coating of the stent graft — effects on platelets, coagulation and complement activation
269
Heparin Coating With Aprotinin Reduces Blood Activation During Coronary Artery Operations
270
Heparin cofactor II (RbHCII) from rock bream (Oplegnathus fasciatus): Molecular characterization, cloning and expression analysis
271
Heparin column analysis of serum type 5 tartrate-resistant acid phosphatase isoforms
272
Heparin conjugated silica nanoparticle synthesis
273
Heparin coupling in inhibition of calcification of vascular bioprostheses
274
Heparin crosslinked chitosan microspheres for the delivery of neural stem cells and growth factors for central nervous system repair
275
Heparin delivery at the site of angioplasty with a nevel drug delivery sleeve
276
Heparin dosing and outcome in acute coronary syndromes: The GUSTO-IIb experience
277
Heparin effect on platelets and fibrinolysis
278
Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity
279
Heparin for acute ischaemic stroke: a never-ending story?
280
Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation
281
Heparin in acute coronary syndromes
282
Heparin in calcification prevention of porcine pericardial bioprostheses
283
Heparin in sepsis treatment
284
Heparin in sepsis treatment – Authorsʹ reply
285
Heparin in the treatment of burns: a review
286
Heparin in unstable angina
287
Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: Effect on haemocompatibility
288
Heparin- induced thrombocytopenia (HIT): a case report of CABG patient
289
Heparin Infusion Prior to Stenting (HIPS) trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia
290
Heparin Initiation Before and After Femoral Arterial Access in Primary Percutaneous Coronary Intervention: Side Effects and Angiographic Success Rates
291
Heparin intercalation into reconstituted collagen I fibrils: Impact on growth kinetics and morphology
292
Heparin interference in whole blood sodium measurements in a pediatric setting
293
Heparin Is More Effective Than Inogatran, a Low-Molecular Weight Thrombin Inhibitor in Suppressing Ischemia and Recurrent Angina in Unstable Coronary Disease
294
Heparin oligosaccharide sequence and size essential for inhibition of pulmonary artery smooth muscle cell proliferation
295
Heparin potentiates collateral growth but not growth of intramyocardial endarteries in dogs with repeated coronary occlusion
296
Heparin preserves nitric oxide activity in coronary endothelium during ischemia-reperfusion injury
297
Heparin prophylaxis in bedridden patients
298
Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition
299
Heparin Resistance During and Post-Intravenous Nitroglycerin Infusion
300
Heparin Reverses Anaphylactoid Shock in a Porcine Model
301
Heparin reverses Rhodamine 123 extrusion by multidrug resistant cells
302
Heparin study sparks controversy among cardiologists
303
Heparin therapy for deep vein thrombosis: from hospital to home
304
Heparin therapy in electrical burns: First study and pictures
305
Heparin Thromboprophylaxis for Medical Inpatients
306
Heparin use complicates cardiological procedures
307
Heparin versus aspirin in ischaemic stroke
308
Heparin versus aspirin in ischaemic stroke
309
Heparin versus aspirin in ischaemic stroke
310
Heparin vs aspirin in acute ischaemic stroke
311
Heparin, cell adhesion, and pathogenesis of inflammatory bow el disease
312
Heparin, Enoxaparin, and Mechanical Prophylaxis Utilization Evaluation in DVT Prophylaxis in a Major Teaching Hospital in West of Iran
313
Heparinase-II-Catalyzed Degradation of N-Propionylated Heparin
314
Heparin-binding activity of feline herpesvirus type 1 glycoproteins
315
Heparin-binding EGF-like growth factor induces expression of lectin-like oxidized LDL receptor-1 in vascular smooth muscle cells
316
Heparin-bonded circuits decrease myocardial ischemic damage
317
Heparin-Bonded Circuits Decrease Myocardial Ischemic Damage: An Experimental Study
318
Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study
319
Heparin-Bonded Covered Stents Versus Bare-Metal Stents for Complex Femoropopliteal Artery Lesions: The Randomized VIASTAR Trial (Viabahn Endoprosthesis With PROPATEN Bioactive Surface [VIA] Versus Bare Nitinol Stent in the Treatment of Long Lesions in Sup
320
Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support
321
Heparin-coated bypass circuits in cardiopulmonary bypass: Improved biocompatibility or not
322
Heparin-coated bypass circuits: effects on inflammatory response in pediatric cardiac operations
323
Heparin-coated circuits and aprotinin prime for coronary artery bypass grafting
324
Heparin-coated circuits and reduced systemic anticoagulation applied to 2500 consecutive first-time coronary artery bypass grafting procedures
325
Heparin-coated circuits for high-risk patients: a multicenter, prospective, randomized trial
326
Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study
327
Heparin-Coated Equipment Reduces the Risk of Oxygenator Failure
328
Heparin-coated Wiktor stents in human coronary arteries (MENTOR Trial)
329
Heparin-conjugated scaffolds with pore structure of inverted colloidal crystals for cartilage regeneration
330
Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2
331
Heparin-doped affinity electromembranes for thrombin purification
332
Heparin-folate-retinoic acid bioconjugates for targeted delivery of hydrophobic photosensitizers
333
Heparin-free hemodialysis in the treatment of hypernatremia in severely burned patients
334
Heparin-functionalized chitosan scaffolds for bone tissue engineering Original Research Article
335
Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications
336
Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents
337
Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM)
338
Heparin-induced aldosterone suppression and hyperkalemia
339
Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis
340
Heparin-Induced Cancer Cell Death Review Article
341
Heparin-induced CVA
342
Heparin-induced hyperkalemia after cardiac surgery
343
Heparin-induced platelet dysfunction and cardiopulmonary bypass
344
Heparin-Induced Thrombocytopeni
345
Heparin-induced thrombocytopenia
346
Heparin-induced thrombocytopenia and cardiac surgery
347
Heparin-induced thrombocytopenia and cardiac surgery
348
Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use
349
Heparin-induced thrombocytopenia and cardiovascular diseases
350
Heparin-induced thrombocytopenia and heart operation: Management with tedelparin
351
Heparin-Induced Thrombocytopenia Associated With Bilateral Adrenal Hemorrhage After Coronary Artery Bypass Surgery
352
Heparin-induced thrombocytopenia in coronary bypass surgery
353
Heparin-Induced Thrombocytopenia in Left Ventricular Assist Device Bridge-to-Transplant Patients
354
Heparin-induced thrombocytopenia in the emergency department
355
Heparin-induced thrombocytopenia is rare in pregnancy
356
Heparin-induced thrombocytopenia with thrombotic sequelae: a review
357
Heparin-induced thrombocytopenia: an overview
358
Heparin-induced thrombocytopenia: bovine versus porcine heparin in cardiopulmonary bypass surgery
359
Heparin-induced thrombocytopenia: clinical manifestations and management strategies
360
Heparinization of gas plasma-modified polystyrene surfaces and the interactions of these surfaces with proteins studied with surface plasmon resonance
361
Heparinized and Saline Solutions in the Maintenance of Arterial and Central Venous Catheters After Cardiac Surgery
362
Heparinized bovine pericardium as a novel cardiovascular bioprosthesis
363
Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance
364
Heparin-like anticoagulant activity of sulphonated poly(ethylene oxide) and sulphonated poly(ethylene oxide)-grafted polyurethane
365
Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5
366
Heparin-like functionalized polymer surfaces: discrimination between catalytic and adsorption processes during the course of thrombin inhibition
367
Heparinoid Anticoagulation and Topical Fibrin Sealant in Heparin-Induced Thrombocytopenia
368
Heparinoid-active two sulfated polysaccharides isolated from marine green algae Monostroma nitidum
369
Heparinoid-active two sulfated polysaccharides isolated from marine green algae Monostroma nitidum
370
Heparin–platelet factor 4 antibodies in patients presenting to the ED with thrombosis
371
Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF
372
Heparin-related thrombosis despite normal platelet counts in vascular surgery
373
Heparin-released extracellular superoxide dismutase is reduced in patients with coronary artery atherosclerosis
374
Heparins in management of acute coronary syndromes without ST-segment elevation
375
Heparin-stimulated expression of extracellular-superoxide dismutase in human fibroblasts
376
Hepatectomy for liver metastases from breast cancer
377
Hepatectomy using traditional Péan clamp–crushing technique under intermittent Pringle maneuver
378
Hepatic “split lesion” in a fatal electrocution case
379
Hepatic “Stem” Cells: Coming Full Circle
380
Hepatic 18F-FDG Uptake Measurements on PET/MR: Impact of Volume of Interest Location on Repeatability
381
Hepatic 5′-AMP-Activated Protein Kinase: Zonal Distribution and Relationship to Acetyl-CoA Carboxylase Activity in Varying Nutritional States
382
Hepatic 7-ethoxyresorufin O-deethylase Activity in eel (Anguilla Anguilla) from The Thames Estuary and Comparisons with other United Kingdom Estuaries
383
Hepatic abscess caused by Brucella US, CT and MRI findings: Case report and review of the literature
384
Hepatic activities of CYP1A and thiamine-dependent enzymes in Baltic salmon (Salmo salar) alevins suffering from the thiamine deficiency M74
385
Hepatic Acyl CoA Oxidase1 Inhibition Modifies Brain Lipids and Electrical Properties of Dentate Gyrus
386
Hepatic adenoma and focal nodular hyperplasia: mr findings with superparamagnetic iron oxide– enhanced mri
387
Hepatic adenomatosis: MRI demonstration with the use of superparamagnetic iron oxide
388
Hepatic allograft abscess with hepatic arterial thrombosis
389
Hepatic Alterations in the Amphibian Sclerophrys regularis as Biomarkers for Habitat Destruction
390
Hepatic alterations in the fish Rhamdia quelen contaminated with Folidol 600®
391
Hepatic Alveolar Echinococcosis
392
Hepatic alveolar echinococcosis: MRI findings
393
Hepatic Alveolar Hydatid Cyst: A Brief Review of Published Cases from Iran in the Last 20 Years
394
Hepatic amino acid and protein metabolism in non-anorectic, moderately cachectic tumor-bearing rats
395
Hepatic amino nitrogen conversion and organ N-contents in hypothyroidism, with thyroxine replacement, and in hypethyroid rats
396
Hepatic amino- to urea-N clearance and forearm amino-N exchange during hypoglycemic and euglycemic hyperinsulinemia in normal man
397
Hepatic anaplerotic outflow fluxes are redirected from gluconeogenesis to lactate synthesis in patients with Type 1a glycogen storage disease
398
Hepatic and biliary biomarkers in rainbow trout injected with sediment extracts from the River Po (Italy)
399
Hepatic and extrahepatic dehydrogenation/isomerization of 5-cholestene-3β,7α-diol: localization of 3β-hydroxy-Δ5-C27-steroid dehydrogenase in pig tissues and subcellular fractions
400
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
401
Hepatic and Extra-hepatic Transcription of Inter-α-inhibitor Family Genes under Normal or Acute Inflammatory Conditions in Rat
402
Hepatic and intestinal cytochrome P450 and conjugase activities in rats treated with black tea theafulvins and theaflavins
403
Hepatic and Intestinal Schistosomiasis: Review
404
Hepatic and renal concentrations of 10 trace elements in crocodiles (Crocodylus niloticus) in the Kafue and Luangwa rivers in Zambia
405
Hepatic and renal concentrations of vitamins E and C in lead- and ethanol-exposed rats. An assessment of their involvement in the mechanisms of peroxidative damage
406
Hepatic and renal metallothionein induction by an oral equimolar dose of zinc, cadmium or mercury in mice
407
Hepatic and skeletal muscle glycogen metabolism in rats with short-term cholestasis
408
Hepatic and splenic sarcoidosis as a cause of hypercalcemia: a case report
409
Hepatic angiomyolipoma with minimal fat content: MR demonstration
410
Hepatic Angiomyolipoma: a Rarely Described Tumor
411
Hepatic angiomyolipoma: Demonstration by out of phase MRI
412
Hepatic angiomyolipoma: Value of proton (fat/water) chemical shift fast low angle shot (FLASH) MR imaging technique in detecting fatty tissue content
413
HEPATIC ANGIOSARCOMA: REPORT OF A CASE WITHOUT A HISTORY OF EXPOSURE TO ENVIRONMENTAL RISK FACTORS
414
Hepatic antioxidant enzymes and total glutathione of Cyprinus carpio exposed to three disinfectants, chlorine dioxide, sodium hypochlorite and peracetic acid, for superficial water potabilization
415
HEPATIC ANTIOXIDANT, OXIDATIVE STRESS an‎d HISTOPATHOLOGICAL CHANGES INDUCED BY NICOTINE IN A GENDER BASED STUDY IN ADULT RATS
416
Hepatic apolipoprotein and LDL receptor gene expression in the genetically hypercholesterolemic (RICO) rat Original Research Article
417
Hepatic Arterial Blood Flow Index Is Associated with the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B Virus Infection
418
Hepatic arterial blood flow velocities: assessment by transcutaneous and intravascular Doppler sonography
419
Hepatic arterial Fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma
420
Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview
421
Hepatic Arterial Infusion Chemotherapy with Cisplatin for TACE-Refractory or -Ineligible Hepatocellular Carcinoma with Child-Pugh Score of 8 or Above
422
Hepatic arterial infusion for hepatic metastases from Colon Cancer
423
Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsifi
424
Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsifi
425
Hepatic arterial pulsatility index in cirrhosis: correlation with portal pressure
426
Hepatic Artery and Portal Vein Doppler Indexes in Non‑alcoholic Fatty Liver Disease Before and After Treatment to Prevent Unnecessary Health Care Costs
427
Hepatic Artery Aneurysms as a Rare but Important Cause of Abdominal Pain; a Case Series
428
Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors
429
Hepatic artery chemotherapy and colorectal liver metastases
430
Hepatic artery chemotherapy and colorectal liver metastases
431
Hepatic artery chemotherapy and colorectal liver metastases
432
Hepatic artery chemotherapy and colorectal liver metastases
433
Hepatic artery embolisation with a novel radiopaque polymer causes extended liver necrosis in pigs due to occlusion of the concomitant portal vein
434
Hepatic artery infusion for liver metastases from colorectal cancer
435
Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: A clinical and pharmacologic evaluation
436
Hepatic artery ligation: a simple and safe technique to treat extrahepatic aneurysms of the hepatic artery
437
Hepatic artery malformations associated with a primary defect in intrahepatic bile duct development
438
Hepatic Artery Pseudoaneurysm ; Simple or Difficult to Diagnose
439
Hepatic artery pseudoaneurysm; a rare complication of Amoebic liver abscess
440
Hepatic Basolateral Plasma High-affinity Ca2+-RATPase is Inhibited by Nitric Oxide and Peroxynitrite Anion
441
Hepatic bile salt flux does not modulate level and activity of the sinusoidal Na+-taurocholate cotransporter (ntcp) in rats
442
Hepatic binding proteins translocating azo dye carcinogen metabolites from cytoplasm into nucleus in rats
443
Hepatic biomarkers of sediment-associated pollution in juvenile turbot, Scophthalmus maximus L.
444
Hepatic biomarkers of xenobiotic metabolism in eighteen marine fish from NW Mediterranean shelf and slope waters in relation to some of their biological and ecological variables
445
Hepatic biotransformation of alkylresorcinols is mediated via cytochrome P450 and β-oxidation: A proof of concept study
446
Hepatic bisegmentectomy 7–8 for a colorectal metastasis
447
Hepatic blood flow and splanchnic oxygen consumption in patients with hepatic encephalopathy before and after high-volume plasmapheresis
448
Hepatic blood flow responses to mechanical stimulation of the skin in anaesthetised rats
449
Hepatic branch vagotomy can block liver regeneration enhanced by ursodesoxycholic acid in 66% hepatectomized rats
450
HEPATIC CAPILLARIASIS IN CHILDREN: REPORT OF 3 CASES IN BRAZIL
451
Hepatic cavernous hemangiomas: Patterns of contrast enhancement on MR fluoroscopy imaging
452
Hepatic cell-specific ATP-binding cassette (ABC) transporter profiling identifies putative novel candidates for lipid homeostasis in mice
453
Hepatic cellular and tissue pathologic response in the mosquito fish, Gambusia affinis, to different time exposure of diethylnitrosamine
454
Hepatic Changes in the Freeze-Tolerant Turtle Chrysemys picta marginata in Response to Freezing and Thawing
455
Hepatic Choristoma: an Unexpected Finding During Cholecystectomy
456
Hepatic clearance of advanced glycation end products (AGEs)—myth or truth?
457
Hepatic CYP1A in winter flounder (Pleuronectes americanus) along the Northeast Coast: Results from the national benthic surveillance project
458
Hepatic CYP1A levels and EROD activity in English sole: biomonitoring of marine contaminants in Vancouver Harbour
459
Hepatic CYP450 gene expression, hematological and biochemical indices in Caspian roach (Rutilus caspius) induced by Endosulfan
460
Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia
461
Hepatic cytochrome P450 reductase-null mice reveal a second microsomal reductase for squalene monooxygenase
462
Hepatic cytochrome P4501A and 7-ethoxyresorufin O-deethylase induction in mullet and common sole as an indicator of toxic organic pollution in Izmir Bay, Turkey
463
Hepatic differentiation of porcine induced pluripotent stem cells in vitro
464
Hepatic DNA adducts and production of mutagenic urine in 2,6-dinitrotoluene-treated B6C3F, male mice
465
Hepatic duct diverticulum
466
Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculation
467
Hepatic dysfunction associated with atenolol
468
Hepatic Dysfunction in Ambulatory Patients With Heart Failure: Application of the MELD Scoring System for Outcome Prediction
469
Hepatic dysfunction in critically ill patients
470
Hepatic Effects of Endothelin: Metabolism of [125I]Endothelin-1 by Liver-Derived Cells
471
Hepatic elemental contents and antioxidant enzyme activities in Algerian mice (Mus spretus) inhabiting a mine area in central Portugal
472
Hepatic encephalopathy and ascites
473
Hepatic encephalopathy and ascites
474
Hepatic encephalopathy and nitric oxide
475
Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?
476
Hepatic Encephalopathy Linked to COVID-19 in a Pediatric Case: A Rare Presentation of COVID-19
477
Hepatic encephalopathy: Clinical aspects and pathogenetic concept
478
Hepatic Encephalopathy: Early Diagnosis in Pediatric Patients With Cirrhosis
479
Hepatic Energy and Substrate Metabolism: A Possible Metabolic Basis for Early Nutritional Support in Cirrhotic Patients
480
Hepatic environment elicits monocyte differentiation into a dendritic cell subset directing Th2 response
481
Hepatic Epithelioid Hemangioendothelioma: A Review of Three Liver Transplant Recipients
482
Hepatic EROD Activity in Flounder (Platichthys flesus) as an Indicator of Contaminant Exposure in English Estuaries
483
Hepatic ethoxyresorufin O-deethylase (EROD) activity in flounder (Platichthys flesus) from contaminant impacted estuaries of the United Kingdom: continued monitoring 1999–2001
484
Hepatic expression of A Disintegrin And Metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases
485
Hepatic expression of regeneration marker genes following partial hepatectomy in the rat : Influence of 1,25-dihydroxyvitamin D3 in hypocalcemia
486
Hepatic expression profiling in smolting and adult coho salmon (Onchorhynchus kisutch)
487
Hepatic Failure After Bariatric Surgery: A Systematic Review
488
Hepatic Failure in a Young Woman Following Ingestion of Tribulus Terrestris
489
Hepatic Failure Related to Itraconazole Use Successfully Treated by Corticosteroids
490
Hepatic fatty acid metabolism in rats fed diets with different contents of C18 : 0, C18 : 1 cis and C18 : 1 trans isomers
491
Hepatic focal nodular hyperplasia in infant antenatally exposed to steroids
492
Hepatic free fatty acids accumulate in experimental steatohepatitis: Role of adaptive pathways
493
Hepatic fructose-metabolizing enzymes and related metabolites: role of dietary copper and gender
494
Hepatic functional reserve in patients with obstructive jaundice: An assessment by the redox tolerance test
495
Hepatic gene expression and lipid parameters in complement C3−/− mice that do not develop ethanol-induced steatosis
496
Hepatic gene expression and plasma albumin concentration related to outcome after attenuation of a congenital portosystemic shunt in dogs
497
Hepatic gene expression and prediction of therapy response in chronic hepatitis C patients
498
Hepatic gene expression profile associated with non-alcoholic steatohepatitis protection by S-nitroso-N-acetylcysteine in ob/ob mice
499
Hepatic gene expression profile in brown trout (Salmo trutta) exposed to traffic related contaminants Original Research Article
500
Hepatic gene expression profiling reveals perturbed calcium signaling in a mouse model lacking both LDL receptor and Apobec1 genes
501
Hepatic gene induction in murine bone marrow after hepatectomy
502
Hepatic glucose metabolism in humans—its role in health and disease
503
Hepatic glucose output response to nicotine and the underlying neural mechanism in rats
504
Hepatic Glutamate Dehydrogenase Activity and the Presence of Ammonia and Urea in the Circulatory Fluid of Channa Gachua in WaterRestricted Condition
505
Hepatic glutaminase—a special role in urea synthesis?
506
Hepatic glutamine metabolism
507
Hepatic glutamine metabolism during endotoxemia in neonatal rats
508
Hepatic glutathione in English sole (Pleuronectes vetulus): Response to complex mixtures of xenobiotics
509
Hepatic glutathione S-transferase activity in flounder collected from contaminated and reference sites along the Polish coast
510
Hepatic glutathione S-transferases from lamprey (Petromyzom marinus): purification and characterization
511
Hepatic granuloma mimicking recurrent lymphoma on ^18F-FDG PET/CT in a patient with primary mediastinal diffuse large B-cell lymphoma
512
Hepatic granulomas associated with brucellosis
513
Hepatic Health and Humoral Immunological Parameters of Common Carp (Cyprinus carpio) Fed Lactic Acid-supplemented Diets
514
Hepatic hemosiderosis in buffalo fish (Ictiobus spp.)
515
Hepatic histology in obese patients undergoing bariatric surgery
516
Hepatic histopathology in two populations of the mummichog, Fundulus heteroclitus
517
Hepatic hyaline globules in an Eclectus parrot (Eclectus roratus)
518
Hepatic hydatid cyst presenting as a cutaneous fistula
519
HEPATIC HYDROTHORAX WITH MODERATE ASCITIS IN A NIGERIAN
520
Hepatic hydrothorax: pathogenesis, diagnosis, and management
521
Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), ,
522
Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection
523
Hepatic Impact of Different Concentrations of Hibiscus rosa Zinc Oxide Nanoparticles on Rats
524
Hepatic inflammatory mass secondary to toothpick perforation of the stomach: triphasic CT appearances
525
Hepatic injury and vitamin A ingestion
526
Hepatic Involvement and Association with Prognosis in COVID-19 Patients: A Single-Centre Report from Iran
527
Hepatic Involvement in Dengue Fever in Children
528
Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C
529
Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del “loss of function” mutations in ferroportin disease
530
Hepatic iron metabolism gene expression profiles in HFE associated Hereditary Hemochromatosis
531
Hepatic iron overload and fibrosis in patients with beta thalassemia major after hematopoietic stem cell transplantation: A pilot study.
532
Hepatic iron overload and hepatocellular carcinoma
533
Hepatic iron overload in alcoholic liver disease: why does it occur and what is its role in pathogenesis?
534
Hepatic iron status and response to therapy in chronic viral hepatitis B and C: A preliminary report
535
Hepatic Ischemia and Reperfusion Injury and Trauma: Current Concepts
536
Hepatic ischemia secondary to hepatic artery ligation: MRI findings
537
Hepatic Ischemia/Reperfusion Injury Is Diminished by Atorvastatin in Wistar Rats
538
Hepatic ischemia-reperfusion injury
539
Hepatic ischemia-reperfusion injury
540
Hepatic levels of metal and metallothioneins in two commercial fish species of the Northern Iberian shelf
541
Hepatic lipase mediates an increase in selective uptake of high-density lipoprotein-associated cholesteryl esters by human Hep 3B hepatoma cells in culture Original Research Article
542
Hepatic lipase mediates lipoprotein uptake into cells via LDL receptor-related protein
543
Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: The Copenhagen City Heart Study
544
Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor
545
Hepatic lipase promoter C-514T polymorphism influences serial changes in HDL cholesterol levels since childhood: the Bogalusa Heart Study
546
Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice
547
Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model
548
Hepatic lipidosis in a common Mynah (Acridotheres tristis) associated with pododermatitis and consumption of broiler pelleted feed
549
Hepatic lipogenic enzyme expression in pigs is affected by selection for decreased backfat thickness at constant intramuscular fat content
550
Hepatic Lobectomy-Case Report of Two Patients, Performed at Chittagong Medical College Hospital
551
Hepatic localisation of rat cysteine dioxygenase
552
Hepatic mesenchymal hamartoma with translocation involving chromosome band 19q13.4: a recurrent abnormality
553
Hepatic metabolism of sulfur amino acids in db/db mice
554
Hepatic metabolism, phase I and II biotransformation enzymes in Atlantic salmon (Salmo Salar, L) during a 12 week feeding period with graded levels of the synthetic antioxidant, ethoxyquin
555
Hepatic metallothionein as a biomarker for metal contamination: age effects and seasonal variation in European flounders (Pleuronectes flesus) from the Severn Estuary and Bristol Channel
556
Hepatic metallothionein concentrations in the golden grey mullet (Liza aurata) – Relationship with environmental metal concentrations in a metal-contaminated coastal system in Portugal
557
Hepatic metastasis complicated by abscess formation
558
Hepatic Microcirculatory Changes Induced by Hepatic Artery Embolization in Rats Original Investigation
559
Hepatic microvascular features in experimental cirrhosis: a structural and morphometrical study in CCl4-treated rats
560
Hepatic mitochondrial transport of glutathione: Studies in isolated rat liver mitochondria and H4IIE rat hepatoma cells
561
Hepatic mono-oxygenase induction in benthic flatfish sampled near coastal pulp mills in British Columbia
562
Hepatic mucosa-associated lymphoid tissue (MALT) lymphoma associated with hepatitis C
563
Hepatic multi-nodular focal fatty metamorphosis in acquired porphyria cutanea tarda: Sonographic, CT, and mri features
564
Hepatic mycotic aneurysms
565
Hepatic myelopathy Case report with review of the literature
566
Hepatic myelopathy with spastic paraparesis
567
Hepatic necroinflammation and severe liver fibrosis in patients with chronic hepatitis B with undetectable HBV DNA and persistently normal alanine aminotransferase
568
Hepatic Necrosis: A Main Presentation of Systemic Lupus Erythematosus in a Previously Healthy Woman
569
Hepatic nodules in liver transplantation candidates: MR imaging and underlying hepatic disease
570
Hepatic Osteodystrophy: a relationship between osteoporotic bone and chronic liver disease
571
Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man
572
Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo
573
Hepatic overlap syndromes
574
Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage
575
Hepatic Oxidative Damages and Glucose Tolerance in Diabetic Rats Exposed to Repeated Oral Doses of Diazinon
576
Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients
577
Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis
578
Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis chronic hepatitis
579
Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy
580
Hepatic portal venous gas
581
Hepatic portal venous gas: clinical significance of computed tomography findings
582
Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects
583
Hepatic protection by perioperative metabolic support?
584
Hepatic protein synthesis rate of liver specimens as a predictor of viability in rat cold ischemia liver transplantation model
585
Hepatic Proteins and Inflammatory Markers in Rheumatoid Arthritis Patients
586
Hepatic pseudocapillarisation and atherosclerosis in ageing
587
Hepatic radiofrequency ablation using perfusion electrodes in a pig model: Effect of the Pringle manoeuvre
588
Hepatic reduction of insulin-like growth factor (IGF)-I and IGF binding protein-3 that results from fasting is not attenuated in genetically obese rats
589
Hepatic regeneration in insulin-like growth factor binding protein-1 transgenic mice
590
Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients, , , ,
591
Hepatic repopulation with stably transduced conditionally immortalized hepatocytes in the Gunn rat
592
Hepatic resection for hepatocellular carcinoma
593
Hepatic resection for hepatocellular carcinoma in Taiwan
594
Hepatic resection for large hepatocellular carcinoma
595
Hepatic resection for malignant melanoma
596
Hepatic resection for metastatic neuroendocrine carcinomas
597
Hepatic resection for recurrent metastatic ovarian cancer
598
Hepatic resection in breast cancer metastases: should it be considered standard treatment?
599
Hepatic resection in metastatic breast cancer: results and prognostic factors
600
Hepatic resection using stapling devices
601
Hepatic resection with vascular isolation and routine supraceliac aortic clamping
602
Hepatic retractor in an ex vivo model
603
Hepatic Rupture After Heimlich Maneuver
604
Hepatic Sarcodosis presenting as portal hypertension in a young boy
605
Hepatic sarcoidosis: MR appearances in patients with chronic liver disease
606
Hepatic Shock Differential Diagnosis and Risk Factors: A Review Article
607
Hepatic Sinusoidal Endothelial Cells Promote Hepatocyte Proliferation Early after Partial Hepatectomy in Rats
608
Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids
609
Hepatic Steatosis
610
Hepatic Steatosis Alleviated by a Novel Metformin and Quercetin Combination Activating Autophagy Through the cAMP/AMPK/SIRT1 Pathway
611
Hepatic Steatosis among Obese Children and Adolescents
612
Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening
613
Hepatic steatosis and insulin resistance: Does etiology make a difference?
614
Hepatic Steatosis and Related Factors in Obese Children Attending National Nutritional Institute
615
Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E
616
Hepatic steatosis in chronic hepatitis B and C: Predictors, distribution and effect on fibrosis
617
Hepatic steatosis in HIV/HCV co-infected patients: Correlates, efficacy and outcomes of anti-HCV therapy: A paired liver biopsy study
618
Hepatic Steatosis in Iranian Patients with Chronic Hepatitis C
619
Hepatic steatosis is associated with a greater prevalence of coronary artery calcification in asymptomatic men
620
Hepatic steatosis: An experimental model for quantification
621
Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyte
622
Hepatic stellate cell activation in genetic haemochromatosis : Lobular distribution, effect of increasing hepatic iron and response to phlebotomy
623
Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis
624
Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis
625
Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers
626
Hepatic stellate cells (Ito-cells) but not collagen IV may partly be responsible for lower portal pressure after reversing secondary biliary cirrhosis in the rat
627
Hepatic stellate cells and the regulation of liver inflammation
628
Hepatic stellate cells are an important cellular site for β-carotene conversion to retinoid
629
Hepatic stellate cells become susceptible to fas-ligand induced apoptosis during transformation to myofibroblasts
630
Hepatic stellate cells do not derive from the neural crest
631
Hepatic stellate cells in human schistosomiasis mansoni: A comparative immunohistochemical study with liver cirrhosis
632
HEPATIC STELLATE CELLS IN THE CONTEXT OF LIVER FIBROSIS
633
Hepatic stem cells
634
Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer
635
Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah−/− knockout mice model
636
Hepatic tissue damage induced in Meriones ungliculatus due to infection with Babesia divergens-infected erythrocytes
637
Hepatic Tissue Engineering Using Scaffolds: State of the Art
638
Hepatic Toxocariasis in a Child: ACase Report from Shiraz, Southern Iran
639
Hepatic triacylglycerols and serum non-esterified fatty acids (NEFA) variations in indigenous water buffalo (Bubalus bubalis) in the province of Khuzestan, Iran
640
Hepatic tumor necrosis factors production and distant organ dysfunction in a murine model of obstructive jaundice
641
Hepatic tumours in childhood: An experience at the Children Hospital and Institute of Child Health, Lahore
642
Hepatic undifferentiated embryonal sarcoma: malignant evolution of mesenchymal hamartoma? Study of one case with immunohistochemical and flow cytometric emphasis
643
Hepatic vagotomy inhibits proliferation of hepatic stellate cells in rats with acute hepatitis
644
Hepatic vascular calcification: An early second trimester sonographic feature of idiopathic infantile arterial calcinosis
645
Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family
646
Hepatic vein to the azygous vein anastomosis for pulmonary arteriovenous fistulae
647
Hepatic vein velocities in children with right ventricular hypertension
648
Hepatic vein waveform in liver cirrhosis: Correlation with Child’s class and size of varices
649
Hepatic veno-occlusive disease with immunodeficiency (VODI): First reported case in the U.S. and identification of a unique mutation in Sp110
650
Hepatic Venous Malformation After Modified Fontan Procedure With Partial Hepatic Vein Exclusion
651
Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy
652
Hepatic viral infections in Yemen between 2000-2005
653
Hepatic von Meyenburg complex simulating biliary cystadenocarcinoma
654
Hepatic, Renal and Cardiovascular Biomarker Variability in Type 2 Diabetes Mellitus Patients with Poor Glycemic Control
655
Hepaticocholecystoduodenostomy compared with Roux-en-y choledochojejunostomy for decompression of the biliary tract
656
Hepatiti C and Ocular urface Dieae Original Reearch Article
657
Hepatitis A 2004 Vaccination in Children: Methods and Findings of a Survey in Two States Original Research Article
658
Hepatitis A and B immunization in persons being evaluated for sexually transmitted diseases
659
Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus
660
Hepatitis A and E: not to be forgotten
661
Hepatitis A and vigorous physical activity
662
Hepatitis A booster vaccination: is there a need?
663
Hepatitis A Chronic Immunity in Iran: A Geographic Information System-Based Study
664
Hepatitis A Chronic Immunity: A Population-Based Seroprevalence Study in Fars Province, Southern Iran
665
Hepatitis A IgG seropositivity and coronary atherosclerosis assessed by angiography
666
HEPATITIS A IN LATIN AMERICA: A CHANGING EPIDEMIOLOGIC PATTERN
667
Hepatitis A in the Eastern Mediterranean Region: A Review on the Prevalence
668
Hepatitis A Infection Presented with Pancytopenia, a Case Series in Children
669
Hepatitis A Is a Health Hazard for Iranian Pilgrims Who Go to Holly Karbala: A Preliminary Report
670
Hepatitis A linked to clotting factors in USA
671
Hepatitis A Prevention Strategies, Haiti Case: Should Rescuers Be Immunized
672
Hepatitis A Seropositivity among First-Year Students of the Medical University in Isfahan, Iran
673
Hepatitis A seropositivity among newly admitted medical students of Isfahan, Kermanshah, and Hamedan: A seroprevalence study
674
Hepatitis a seroprevalence among young adults: Effects of ACIP immunization recommendations
675
Hepatitis A Seroprevalence and Associated Risk Factors: A Community-based Cross-sectional Study in Shahrekord, Iran
676
Hepatitis A Vaccination among Thai Medical Students: A Questionnaire Study
677
Hepatitis A vaccine failure
678
Hepatitis A vaccine for Israeli children
679
Hepatitis A vaccine for secondary hepatitis A infection
680
Hepatitis A vaccine for secondary hepatitis A infection
681
Hepatitis A vaccine for secondary hepatitis A infection
682
Hepatitis A vaccine for secondary hepatitis A infection
683
Hepatitis A vaccine for secondary hepatitis A infection
684
Hepatitis A vaccine in the last-minute traveler
685
Hepatitis A virus – a general overview
686
Hepatitis A Virus and Coronary Artery Diseases
687
Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran
688
Hepatitis A virus in environmental water samples from the Amazon Basin
689
Hepatitis A Virus Infection
690
Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV
691
Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers
692
Hepatitis A virus infection: Is it an important hazard to public health?
693
Hepatitis A Virus Seropositivity in Nurses and Paramedical Personnel at a University Hospital in North Iran
694
Hepatitis A virus vaccination in Iranian soldiers needs more attention
695
Hepatitis A Virus: Is Vaccination Necessary in Middle East?
696
Hepatitis A Virus: Seroepidemiological Study in Fars Province
697
Hepatitis A with Pleural Effusion, Ascites and Acalculous Cholecystitis
698
Hepatitis after intravenous buprenorphine misuse in heroin addicts
699
Hepatitis agent cloned and designated hepatitis G virus
700
Hepatitis and community: The current scenario and a roadmap for 2030
701
Hepatitis and death following vaccination with 17D-204 yellow fever vaccine
702
Hepatitis and HIV screening, education, and treatment for adults with serious mental illness
703
Hepatitis Awareness Bus: A Model for Finding Unknown Hepatitis B and C Infections
704
Hepatitis B among homeless and other impoverished US military veterans in residential care in Los Angeles
705
Hepatitis B and C among Patients Infected with Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors
706
Hepatitis B and C among thalassemiac patients in Iran: A multicenter study
707
Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: Seroprevalence and associated factors
708
Hepatitis B and C and the Role of Non-specialists on Disease Elimination
709
Hepatitis B and C in HIV-infected patients : Prevalence and prognostic value
710
Hepatitis B and C infection in first-time blood donors in Karachi – a possible subgroup for sentinel surveillance
711
Hepatitis B and C Infections Among Pediatric Patients with Sickle Cell Disease at a Tertiary Hospital in Nigeria
712
Hepatitis B and C Infections and Different Genotypes of HCV Among Sickle Cell Anemia Patients in Ahvaz, South-Western Iran
713
Hepatitis B and C Infections in Hamadan Province during 2004-2009
714
Hepatitis B and C knowledge among Saudi dental patients
715
Hepatitis B and C viral infection: prevalence, knowledge, attitude and practice among barbers and clients in Gharbia governorate, Egypt
716
Hepatitis B and C Viral Infection: Prevalence, Knowledge, Attitude, Practice, and Occupational Exposure among Healthcare Workers of Jimma University Medical Center, Southwest Ethiopia
717
Hepatitis B and C viral infections in chronic liver disease: a populationbased study in Qatar
718
Hepatitis B and C virus hepatocarcinogenesis: Lessons learned and future challenges
719
Hepatitis B and C virus infection and the risk of atherosclerosis in a general population
720
Hepatitis B and C: An alarming situation in Southern part of Khyber Pakhtunkhwa, Pakistan
721
Hepatitis B and C: Prevention is better than cure
722
Hepatitis B and health-care workers
723
Hepatitis B and health-care workers
724
Hepatitis B and health-care workers
725
Hepatitis B and health-care workers
726
Hepatitis B and Hepatitis C in Patients with Inherited Disorders of Hemoglobin in Sistan and Baluchistan Province, Iran
727
Hepatitis B and Hepatitis C Seroprevalence in the Center of Sanliurfa Province From Southeastern Anatolia Region and Related Risk Factors
728
Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: A survey by serologic and molecular methods
729
Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and Differences
730
Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda
731
Hepatitis B and its Relationship With Oxidative Stress
732
Hepatitis B associated liver failure following bone marrow transplantation
733
Hepatitis B Awareness and Knowledge in Asian Communities in British Columbia
734
Hepatitis B Birth Dose among Children in District 2 Hospital, Ho Chi Minh City, Vietnam: Prevalence and Associated Factors
735
Hepatitis B booster vaccination for healthcare workers
736
Hepatitis B Core Antibody ImmunoglobulinMin Blood Donors With a History of Hepatitis B Virus Infection
737
HEPATITIS B e ANTIGEN AND THE RISK OF HEPATOCELLULAR CARCINOMA
738
Hepatitis B e Antigen-Negative Chronic Hepatitis B
739
Hepatitis B envelope protein mutants
740
Hepatitis B epidemiology and cultural practices in Amerindian populations of Amazonia: The Tupí-Mondé and the Xavánte from Brazil
741
Hepatitis B genotypes and the response to interferon therapy
742
Hepatitis B Genotypes in Iran
743
Hepatitis B genotypes in patients with acute hepatitis B virus infection
744
Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update
745
Hepatitis B immunisation in chronically transfused recipients
746
Hepatitis B immunisation in Singapore
747
Hepatitis B Immunization in Health Care Workers: Needs and Opportunities
748
Hepatitis B immunization in postpartum women
749
Hepatitis B in a high prevalence New Zealand population: A mathematical model applied to infection control policy
750
Hepatitis B in China
751
Hepatitis B infection among Asian American Pacific Islanders in the Rocky Mountain area
752
Hepatitis B Infection among Korean Americans in Colorado: Evidence of the Need for Serologic Testing and Vaccination
753
Hepatitis B infection among Nigerian children admitted to a children’s emergency room
754
Hepatitis B Infection among Patients Receiving Chronic Hemodialysis at the Royal Medical Services in Jordan
755
Hepatitis B Infection during Renal Replacement Therapy
756
Hepatitis B infection in Eastern Indian families: Need for screening of adult siblings and mothers of adult index cases
757
Hepatitis B infection in Eastern Mediterranean Region: challenges and the way forward
758
Hepatitis B Infection in Hemodialysis Patients in Tehran Province, Iran
759
Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey
760
Hepatitis B infection: Pathogenesis and management
761
Hepatitis B Infection: Prevalence and Response to Vaccination among Health Care Workers in Babol, Northern Iran
762
Hepatitis B is a Serious Health Problem in Some Parts of Iran; Sistan and Baluchestan Province
763
Hepatitis B Knowledge Among Healthy Volunteers in Duhok City, Kurdistan Region, Iraq
764
Hepatitis B Knowledge Among Iranian Adolescents: A National Survey
765
Hepatitis B or hepatitis C and human immunodeficiency virus infection
766
Hepatitis B pregenomic RNA splicing—The products, the regulatory mechanisms and its biological significance
767
Hepatitis B prevalence among workers in Turkey at low risk for hepatitis B exposure
768
Hepatitis B Prevention Education and Afghan Immigrant Students
769
Hepatitis B reactivation after lamivudine
770
Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review
771
Hepatitis B Recurrence After Liver Transplantation: A Single Center Experiences and Review the Literature
772
Hepatitis B resistance in Iran
773
Hepatitis B Seroconversion Rate After Primary Immunization Series with Newly Introduced Pentavalent Vaccine: A Report of Local Study in Alborz Province, Iran, 2016
774
Hepatitis B seromarkers, hepatitis C antibody, and risk behaviors in married couples, a bordered province of western Thailand
775
Hepatitis B Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province in 2013
776
Hepatitis B Seroprevalence and the Relationship Between Being Hepatitis B Vaccinated and Infected with Social Determinants of Health: Manisa, 2014
777
Hepatitis B Splice-Generated Protein Antibodies in Syrian Chronic Hepatitis B Patients: Incidence and Significance
778
Hepatitis B Stigma and Knowledge among Vietnamese in Ho Chi Minh City and Chicago
779
Hepatitis B surface antibody purification with hepatitis B surface antibody imprinted poly(hydroxyethyl methacrylate-N-methacryloyl-l-tyrosine methyl ester) particles
780
Hepatitis B surface antibody response of household contacts of hepatitis B virus carriers in Palestine
781
Hepatitis B Surface Antigen and Viral DNA Detection and Prevalence in Nigeria
782
Hepatitis B surface antigen carrier rate in unvaccinated and vaccinated children with thalassaemia major at Bahawal Victoria Hospital, Bahawalpur, Pakistan
783
HEPATITIS B SURFACE ANTIGEN DISAPPEARANCE AND HEPATITIS B SURFACE ANTIGEN SUBTYPE: A PROSPECTIVE, LONG-TERM, FOLLOW-UP STUDY OF JAPANESE RESIDENTS OF OKINAWA, JAPAN WITH CHRONIC HEPATITIS B VIRUS INFECTION
784
Hepatitis B Surface Antigen Prevalence among Pregnant Women in Rafsanjan City, Iran, 2003
785
Hepatitis B surface antigen prevalence in pregnant women: A cross‑sectional survey in Iran
786
Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria
787
Hepatitis B Surface Antigen, Hepatitis C Virus Antibody, Body Mass Index, and Alcohol Drinking among Workers with Elevated Serum Alanine Aminotransferase
788
Hepatitis B surface antigenemia (HBsAg) among pregnant women in southern Nigeria
789
Hepatitis B surface antigen-negative, but HBV DNA-positive patients in Bangladesh
790
Hepatitis B testing among Vietnamese American men
791
Hepatitis B transmission from contaminated cryopreservation tank
792
Hepatitis B vaccination after liver transplantation as a strategy to discontinue prophylaxis with hepatitis B immune globulin
793
Hepatitis B vaccination among primary health care workers in Northwest Pakistan
794
HEPATITIS B VACCINATION AND INFANTILE IDIOPATHIC THROMBOCYTOPENIC PURPURA
795
Hepatitis B vaccination coverage among Iranian children aged 15–26 months in 2006
796
Hepatitis B Vaccination Coverage Among Iranian Medical Students and Nursing Staff
797
Hepatitis B Vaccination Coverage and Its Associated Factors in Nurses of Imam Reza (AS) Hospital in Kermanshah
798
Hepatitis B Vaccination Coverage and Sharp Injuries Among Healthcare Workers in Hamadan, Iran
799
Hepatitis B vaccination coverage in medical students at a medical college of Mirpurkhas
800
Hepatitis B Vaccination Coverage, HBS-Ab Level and its Related Factors among Dentistry and Medical Students
801
Hepatitis B Vaccination Efficacy in Iranian Healthcare Workers: A Meta-Analysis Study
802
Hepatitis B vaccination follow-up
803
Hepatitis B Vaccination in Bangladesh: a Suggestion Based on Current Evidence
804
Hepatitis B Vaccination in Chronic Kidney Disease: Review of Evidence in Non-Dialyzed Patients
805
Hepatitis B vaccination in correctional health care workers
806
Hepatitis B vaccination in correctional health care workers
807
Hepatitis B vaccination of babies in Melanesia
808
Hepatitis B vaccination of health care workers in Saudi Arabia
809
Hepatitis B vaccination program at a New York City hospital: Seroprevalence, seroconversion, and declination, ,
810
Hepatitis B Vaccination Reliability in Celiac Disease
811
Hepatitis B Vaccination Status in Dental Practitioners: Local Horrifying Report, National Considerable Issue, and Global Health Impact
812
Hepatitis B vaccination strategy for newborn babies
813
Hepatitis B Vaccination: Needs a Revision
814
Hepatitis B vaccination: to boost or not to boost?
815
Hepatitis B Vaccine Acceptability among Nurses: A Theory Based Conceptualization
816
Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy
817
Hepatitis B vaccine booster dose: Low-dose recombinant hepatitis B vaccines as a booster dose,
818
Hepatitis B vaccine boosting among young healthy adults
819
Hepatitis B vaccine boosting: the debate continues
820
Hepatitis B Vaccine Coverage and the Immune Response in Children under ten years old in Sana’a, Yemen
821
Hepatitis B vaccine in patients on haemodialysis
822
Hepatitis B vaccine, hepatitis C virus infection, and haemodialysis
823
Hepatitis B Vaccine: Immunity, Efficacy and Types.
824
Hepatitis B Viral DNA Among HBs Antigen Negative Healthy Blood Donors
825
Hepatitis B viral genotypes and lamivudine resistance
826
Hepatitis B Viral Markers in Surface Antigen Negative Blood Donors: The Need to Look Beyond Antibody Negativity
827
Hepatitis B viral resistance: mechanisms and diagnosis
828
Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling
829
Hepatitis B Virus (HBV) and Occult Hepatitis B Virus (OBI) in Hemodialysis Patients: An Epidemiological Observational Study in Kerman, Iran (2022-2023)
830
Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics
831
Hepatitis B Virus (HBV) Infection among Pregnant Women in Makurdi, Nigeria
832
Hepatitis B virus (HBV) vaccine-induced escape mutants of HBV S gene among children from Qidong area, China
833
Hepatitis B Virus / Human Immunodeficiency Virus Co-Infection and Its Hepatocarcinogenic Potential in Sub-Saharan Black Africans
834
Hepatitis B virus among maintainence haemodialysis patients: A report from Karachi, Pakistan
835
Hepatitis B virus among schoolchildren in an endemic area in Egypt over a decade: Impact of hepatitis B vaccine
836
Hepatitis B virus and celiac disease
837
Hepatitis B Virus and Cytomegalovirus Infections Disrupt Sperm Parameters in Males through Decreasing Mitochondrial Membrane Potential: A Case-control Study
838
Hepatitis B virus and hepatocellular carcinoma
839
Hepatitis B virus and HIV infection among patients with primary hepatocellular carcinoma in Kampala, Uganda
840
Hepatitis B virus and host factors
841
Hepatitis B Virus and Malaria Co-infection Causing Significant Changes in Hematological and Liver Function Indices in a Cohort of Subjects in Ilorin, Nigeria
842
Hepatitis B Virus Antibody Levels in High-Risk Health Care Workers
843
Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunised donor
844
Hepatitis B Virus Complications of Pregnancy After Kidney Transplantation
845
Hepatitis B Virus Core Promoter Mutations in Patients With Chronic Hepatitis B and Hepatocellular Carcinoma in Bucharest, Romania
846
Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C
847
Hepatitis B Virus DNA is Absent in Lebanese Blood Donors Who Are Positive for Both Anti-Hbc and Anti-Hbs Antibodies
848
Hepatitis B virus DNA level Among the Seropositive Afghan Immigrants, Southern Iran
849
Hepatitis B virus DNA level as predictor of response to therapy with interferon-alpha-2b (PDferon) in chronic hepatitis B infection
850
Hepatitis B virus E antigen but not HBV core is presented to specific CD4+ T cells via the endogenous antigen processing pathway
851
Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro
852
Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors
853
Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression
854
Hepatitis B virus genetic diversity in Latin America
855
Hepatitis B virus genetic variability and evolution
856
Hepatitis B Virus Genome Asymmetry in Hepatocellular Carcinoma
857
Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor β Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection
858
Hepatitis B Virus Genotype G Infection in a Turkish Patient Undergoing Hemodialysis Therapy
859
Hepatitis B virus genotypes and extrahepatic manifestations
860
Hepatitis B Virus Genotypes Distribution with HBsAg Positive in the North of Iran (Mazandaran) During 2011-2014
861
Hepatitis B Virus Genotypes in Eastern Azerbaijan, Northwest Iran
862
Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific region
863
Hepatitis B Virus Genotypes, Epidemiological Characteristics, and Clinical Presentation of HBV Chronic Infection in Immigrant Populations Living in Southern Italy
864
Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran
865
Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran
866
Hepatitis B virus Genotyping Among Patients With Cirrhosis
867
Hepatitis B Virus Immunity Status and Booster Dose Efficacy in Health Sciences Students: An Interventional Study
868
Hepatitis B virus in cervicovaginal lavage samples of pregnant women in Gorgan city, north of Iran
869
Hepatitis B virus induced hepatocellular carcinoma
870
Hepatitis B Virus Infection among Health Colleges’ Students in Aseer Region, Southwestern Saudi Arabia
871
Hepatitis B virus infection among staff in three hospitals in Khartoum, Sudan, 2006–07
872
Hepatitis B Virus Infection and Exposure Among Foreign-Born Asian Americans in the U.S.
873
Hepatitis B Virus Infection and Oral Lichen Planus: A Report from Northeast of Iran
874
Hepatitis B Virus Infection and Oral Lichen Planus: A Report from Northeast of Iran
875
Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma
876
Hepatitis B Virus Infection during Pregnancy: Transmission and Prevention
877
Hepatitis B Virus Infection Flare Induced Acute-on-chronic Liver Failure After COVID-19 Vaccination: A Case Report
878
HEPATITIS B VIRUS INFECTION IN AN ANTI-HBC NEGATIVE PATIENT: A CASE REPORT
879
Hepatitis B virus infection in Iran
880
Hepatitis B Virus Infection in Iran: A Systematic Review
881
Hepatitis B Virus Infection in Iran: Current Knowledge, Future Plans
882
Hepatitis B Virus Infection in Iranian Hemodialysis Patients A Systematic Review and Meta-Analysis
883
Hepatitis B virus infection in lymphatic tissues in inactive hepatitis B carriers
884
Hepatitis B Virus Infection in Patients with Blood Disorders: A Concise Review in Pediatric S
885
Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis
886
Hepatitis B Virus Infection in Vaccinated Children and Adolescents with HBsAg-positive Parents: Is Routine Vaccination Sufficient?
887
Hepatitis B Virus Infection Serology and the Associated Risk Factors Among Patients With HIV in Shiraz, Iran
888
Hepatitis B virus infection without immunological markers after open-heart surgery
889
Hepatitis B virus infection: Current status
890
Hepatitis B Virus Infection; A Vanishing Disease in Iranian Children
891
Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis
892
Hepatitis B virus large surface protein: function and fame
893
Hepatitis B virus mutants and efficacy of vaccination
894
Hepatitis B virus mutants and efficacy of vaccination
895
Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation
896
Hepatitis B virus precore mutants in serum and liver of Southern African Blacks with hepatocellular carcinoma
897
Hepatitis B Virus PreS Variant and Hepatocellular Carcinoma
898
Hepatitis B Virus preS2 Domain Promotes Angiogenesis in Hepatocellular Carcinoma via Transcriptional Activation of VEGFA Promoter
899
Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response
900
Hepatitis B Virus Reactivation Potential Risk Factors in Hepatocellular Carcinoma via Transcatheter Arterial Chemoembolization: A Retrospective Research
901
Hepatitis B virus replication and viral antigen synthesis in hepatocyte lines derived from normal human liver
902
Hepatitis B virus resistance to antivirals: clinical implications and management
903
Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving Chemotherapy
904
Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis
905
Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese
906
Hepatitis B Virus Should not be Forget in Health Care Worker
907
Hepatitis B virus subtypes and lamivudine resistance
908
Hepatitis B Virus Surface Antigen (HBsAg) Mutations Are Rare but Clustered in Immune Epitopes in Chronic Carriers from Sistan-Balouchestan Province, Iran
909
Hepatitis B Virus Surface Antigen Variants Clustered Within Immune Epitopes in Chronic Hepatitis B Carriers from Hormozgan Province, South of Iran
910
Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13 676 relatives with hepatocellular carcinoma
911
Hepatitis B Virus Vaccination in Hemodialysis Patients: A Necessity for Individualizing of Immunization?
912
Hepatitis B Virus Vaccine immune response in Egyptian children 15-17 years after primary immunization; should we provide a booster dose?
913
Hepatitis B virus viral dynamics: effects of drug dose and baseline alanine aminotransferase
914
Hepatitis B virus X antigen and aflatoxin B1 synergistically cause hepatitis, steatosis and liver hyperplasia in transgenic zebrafish
915
Hepatitis B virus X gene is implicated in liver carcinogenesis
916
Hepatitis B virus X mediates podocyte pyroptosis by regulating the ROS/NLRP3 signaling pathway in hepatitis B virus-associated glomerulonephritis
917
Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response
918
Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection
919
Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression
920
Hepatitis B virus X protein interacts with NF-KB inhibitors
921
Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16INK4a expression via DNA methylation
922
Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3
923
Hepatitis B virus X protein stimulates the Hedgehog–Gli activation through protein stabilization and nuclear localization of Gli1 in liver cancer cells
924
Hepatitis B Virus X Protein Up-Regulates AKR1C1 Expression Through Nuclear Factor-Y in Human Hepatocarcinoma Cells
925
Hepatitis B virus YMDD-motif mutations with emergence of lamivudine-resistant mutants: a threat to recovery
926
Hepatitis B Virus, Hepatitis C Virus Markers and Serum Alanine Amino-Transferase (ALT) Levels, in a Young Adult Population of Sylhet District
927
Hepatitis B Virus-associated Glomerulonephritis
928
Hepatitis B Virus-associated Nephropathy An International Data Analysis
929
Hepatitis B viruses and cancerogenesis
930
Hepatitis B viruses: Reverse transcription a different way
931
Hepatitis B virus-induced hepatocellular carcinoma
932
Hepatitis B virus-infected cells can be eliminated by the cytotoxic T cell-mediated immune reaction. Fas ligand, recently detected on the surface of cytotoxic T cell, is thought to induce cells to apoptosis by adhering to Fas antigen. Aims/Methods: To eva
933
Hepatitis B virus-related vasculitis manifesting as severe peripheral neuropathy following influenza vaccination
934
Hepatitis B, C virus co-infection and behavioral risks in HIV-positive patients in southern Iran
935
Hepatitis B, Hepatitis C and HIV seroprevalence in critically ill emergency medicine department patients in a tertiary inner city hospital in Istanbul, Turkey
936
Hepatitis B, Hepatitis C and Human Immunodeficiency Virus Seropositivity Among Children in Kabul, Afghanistan: A Cross-Sectional Study
937
Hepatitis B, Hepatitis C, and Human Immune deficiency Virus Seroconversion Positivity Rates and Their Potential Risk Factors Among Patients on Maintenance Hemodialysis in Cameroon
938
Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection in Multi-Transfused Thalassemic Patients, Kermanshah, Iran, 2015
939
Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection in Multi-Transfused Thalassemic Patients, Kermanshah, Iran, 2015
940
Hepatitis B, hepatitis C, HIV, and VDRL seroprevalence of blood donors in Mersin, Turkey*
941
Hepatitis B: Epidemiology and prevalence in Iran, during 2002-2014
942
Hepatitis B: Knowledge, Vaccine Situation and Seroconversion of Dentistry Students of a Public University
943
Hepatitis B: Reflections on the current approach to antiviral therapy
944
Hepatitis BMarkers in Isfahan, Central Iran: APopulation-Based Study
945
Hepatitis B-Related Concerns and Anxieties Among People With Chronic Hepatitis B in Australia
946
Hepatitis C (HCV) Viremic Rate and its Correlation to Demographic Factors among HCV Confirmed Iranian Blood Donors
947
Hepatitis C among Hemodialysis Patients: A Review on Epidemiologic, Diagnostic, and Therapeutic Features
948
Hepatitis C among Hemodialysis Patients: Impact of Strict Adherence to Universal Precautions
949
Hepatitis C among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors
950
HEPATITIS C AMONG YOUNG MALE OFFENDERS ADMITTED TO THE CENTRAL JAIL, LAHORE
951
Hepatitis C and alcohol
952
Hepatitis C and B-cell lymphoma: the hemato-hepatologist linkage
953
Hepatitis C and B-cell non-Hodgkin’s lymphoma: a geographicallyvariable association?
954
Hepatitis C and blood transfusion among children attending the Sickle Cell Clinic at Mulago Hospital, Uganda
955
Hepatitis C and Depression
956
Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran
957
Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran
958
Hepatitis C and Hepatitis B Virus Infection: Epidemiology and Risk Factors in a Large Cohort of Pregnant Women in Lorestan, West of Iran
959
Hepatitis C and HIV infection: biological, clinical, and therapeutic implications
960
Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems
961
Hepatitis C and liver transplantation
962
Hepatitis C and pulmonary fibrosis
963
Hepatitis C and renal failure
964
Hepatitis C and Steatosis
965
Hepatitis C and Teens
966
Hepatitis C and Teens
967
Hepatitis C and the correctional population
968
Hepatitis C and the heart: to beat or not to beat
969
Hepatitis C and thyroid autoimmunity: is there a link?
970
Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013
971
Hepatitis C at work place: A survey of Occupational Health and Safety Knowledge and Practice in Beauty Therapy Industry
972
Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era
973
Hepatitis C detection
974
Hepatitis C detection
975
Hepatitis C genotype and associated risks factors of patients at University Kebangsaan Malaysia Medical Centre
976
Hepatitis C Genotypes Distribution in Intravenous Drug Users in Tehran
977
Hepatitis C Genotypes in Hemophilia Patients in Iran
978
Hepatitis C Genotypes in Hemophilia Patients in Iran
979
Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma
980
HEPATITIS C IN A COMMUNITY IN UPPER EGYPT: I. CROSS-SECTIONAL SURVEY
981
Hepatitis C in Australia: Impact of a Mass Media Campaign Original Research Article
982
Hepatitis C in haemophilia patients in the Netherlands
983
Hepatitis C in Hemodialysis Centers of Golestan Province, Northeast of Iran (2005)
984
Hepatitis C in hemodialysis patients needs more attention for control and review the risk factors
985
Hepatitis C in Iran. How Extensive of a Problem Is It?
986
Hepatitis C in Pakistan: A Review of Available Data
987
HEPATITIS C IN PERU: RISK FACTORS FOR INFECTION, POTENTIAL IATROGENIC TRANSMISSION, AND GENOTYPE DISTRIBUTION
988
Hepatitis C in State Correctional Facilities
989
Hepatitis C in the Eastern Mediterranean Region
990
Hepatitis C in the patient with human immunodeficiency virus infection
991
Hepatitis C Infection Among HIV-Positive Injection Drug Users and Non-Injection-Drug Users in Tajikistan
992
Hepatitis C infection and autoimmune hemolytic anemia in a patient with colon B-cell non-hodgkin lymphoma: a case report
993
Hepatitis C infection and polymyositis
994
Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis
995
Hepatitis C infection from anti-D immunoglobulin
996
Hepatitis C Infection in Egyptian Psoriatic Patients: Prevalence and Correlation with Severity of Disease
997
Hepatitis C infection in Iran; A review article
998
Hepatitis C Infection in the General Population of Iran: A Systematic Review
999
Hepatitis C infection increases the risk of new-onset diabetes after transplantation in liver allograft recipients
1000
Hepatitis C infection is characterized by a high incidence of liver cirrhosis, frequently requiring liver transplantation. After orthotopic liver transplantation, recurrence of hepatitis C virus infection is common, but often difficult to differentiate fr